Immunogenicity and immunoprotection of recombinant PEB1 in Campylobacter-jejuni-infected mice

被引:13
作者
Du, Lian-Feng [1 ]
Li, Zhen-Jiang [1 ]
Tang, Xian-Ying [1 ]
Huang, Jun-Qiong [1 ]
Sun, Wan-Bang [1 ]
机构
[1] Zunyi Med Coll, Dept Immunol, Zhuhai 519041, Guangdong, Peoples R China
关键词
Campylobacter jejuni; Prokaryotic expression; Immunogenicity;
D O I
10.3748/wjg.14.6244
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To construct a prokaryotic expression vector carrying Campylobacter jejuni peb1A gene and express it in Escherichia coli. Immunoreactivity and antigenicity of rPEB1 were evaluated. The ability of rPEB1 to induce antibody responses and protective efficacy was identified. METHODS: peb1A gene was amplified by PCR, target gene and prokaryotic expression plasmid pET28a (+) was digested with BamHI and XhoI, respectively. DNA was ligated with T4 DNA ligase to construct recombinant plasmid pET28a(+)-peb1A. The rPEB1 was expressed in E coli BL21 (DE3) and identified by SDS-PAGE. BALB/c mice were immunized with rPEB1. ELISA was used to detect the specific antibody titer and MTT method was used to measure the stimulation index of spleen lymphocyte transformation. RESULTS: The recombinant plasmid pET28a (+)-peb1A was correctly constructed. The expression output of PEB1 protein in pET28a (+)-peb1A system was approximately 33% of total proteins in E. coli. The specific IgG antibody was detected in serum of BALB/c mice immunized with rPEB1 protein. Effective immunological protection with a lower sickness incidence and mortality was seen in the mice suffering from massive C jejuni infection. CONCLUSION: rPEB1 protein is a valuable candidate for C jejuni subunit vaccine. (C) 2008 The WJG Press. All rights reserved.
引用
收藏
页码:6244 / 6248
页数:5
相关论文
共 15 条
[1]   Campylobacter jejuni lipopolysaccharides from Guillain-Barre syndrome patients induce IgG anti-GM1 antibodies in rabbits [J].
Ang, CW ;
Endtz, HP ;
Jacobs, BC ;
Laman, JD ;
de Klerk, MA ;
van der Meché, FGA ;
van Doorn, PA .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 104 (02) :133-138
[2]   SAFETY AND IMMUNOGENICITY OF A PROTOTYPE ORAL WHOLE-CELL KILLED CAMPYLOBACTER VACCINE ADMINISTERED WITH A MUCOSAL ADJUVANT IN NONHUMAN-PRIMATES [J].
BAQAR, S ;
BOURGEOIS, AL ;
SCHULTHEISS, PJ ;
WALKER, RI ;
ROLLINS, DM ;
HABERBERGER, RL ;
PAVLOVSKIS, OR .
VACCINE, 1995, 13 (01) :22-28
[3]   IMMUNOGENICITY AND PROTECTIVE EFFICACY OF A PROTOTYPE CAMPYLOBACTER KILLED WHOLE-CELL VACCINE IN MICE [J].
BAQAR, S ;
APPLEBEE, LA ;
BOURGEOIS, AL .
INFECTION AND IMMUNITY, 1995, 63 (09) :3731-3735
[4]   Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity [J].
Baqar, S ;
Bourgeois, AL ;
Applebee, LA ;
Mourad, AS ;
Kleinosky, MT ;
Mohran, Z ;
Murphy, JR .
INFECTION AND IMMUNITY, 1996, 64 (12) :4933-4939
[5]   Campylobacter jejuni in Guillain-Barre syndrome [J].
Hughes, R .
LANCET NEUROLOGY, 2004, 3 (11) :644-644
[6]   Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barre syndrome [J].
Jacobs, BC ;
vanDoorn, PA ;
Schmitz, PIM ;
TioGillen, AP ;
Herbrink, P ;
Visser, LH ;
Hooijkaas, H ;
vanderMeche, FGA .
ANNALS OF NEUROLOGY, 1996, 40 (02) :181-187
[7]   ISOLATION AND CHARACTERIZATION OF 2 CAMPYLOBACTER GLYCINE-EXTRACTED PROTEINS THAT BIND TO HELA-CELL MEMBRANES [J].
KERVELLA, M ;
PAGES, JM ;
PEI, ZH ;
GROLLIER, G ;
BLASER, MJ ;
FAUCHERE, JL .
INFECTION AND IMMUNITY, 1993, 61 (08) :3440-3448
[8]   Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice [J].
Pei, ZH ;
Burucoa, C ;
Grignon, B ;
Baqar, S ;
Huang, XZ ;
Kopecko, DJ ;
Bourgeois, AL ;
Fauchere, JL ;
Blaser, MJ .
INFECTION AND IMMUNITY, 1998, 66 (03) :938-943
[9]  
PEI ZH, 1991, J BIOL CHEM, V266, P16363
[10]  
PEI ZH, 1993, J BIOL CHEM, V268, P18717